West Pharmaceutical Services | WST - Current Assets

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
267.71

West Pharmaceutical Services reported $1.83B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Align Technology USD 2.62B 82.47M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Cerus USD 167.13M 1.41M Sep/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Dentsply International USD 2.02B 49M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
ICU Medical USD 1.19B 16.74M Dec/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
J&J USD 59.17B 3.55B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Neogen USD 590M 15.42M Dec/2025
OraSure Technologies USD 261.91M 21.1M Dec/2025
Quidel USD 1.45B 80.6M Dec/2025
Repligen USD 1.14B 40.9M Dec/2025
Rockwell Medical USD 31.61M 1.42M Jun/2025
Solventum Corp USD 3.86B 548M Dec/2025
STAAR Surgical USD 311.54M 9.66M Dec/2025
Terumo JPY 815.56B 71.48B Dec/2025
Utah Medical Products USD 97.74M 1.21M Dec/2025
West Pharmaceutical Services USD 1.83B 151.4M Mar/2026